Background
Following the results of the PlaNeT‐2 randomized controlled trial showing decreased morbidity and mortality in neonates transfused at a threshold of 25 versus 50 × 109 platelets/L, a protocol supporting restrictive platelet transfusions was established in 2019 at the Sainte‐Justine Hospital neonatal intensive care unit (NICU). This study aimed to: (1) determine the impact of a local restrictive transfusion protocol on the number of platelet transfusions and donor exposure; (2) compare platelet‐transfusion determinants and justifications before and after its implementation.
Study design and methods
Prospective observational cohort chart‐review study comparing all neonates consecutively admitted to the NICU during two 5‐months periods: 2013 (before; N = 401) versus 2021 (after; N = 402). Possible determinants were assessed via logistic regressions and justifications via a questionnaire.
Results
Mean (± standard deviation) gestational age and birth weight were 34.9 ± 4.2 weeks and 2.5 ± 1.0 kg, respectively. In 2021, 5.0% were platelet‐transfused versus 9.2% in 2013 (p = .027). Platelet transfusions decreased from a mean of 2.6 ± 1.7 in 2013 to 1.4 ± 0.7 in 2021 (p = .045). Adherence to protocol thresholds was of 70%. After protocol implementation, no infant received ≥4 platelet transfusions nor was exposed to ≥4 donors, compared to 29.7% and 21.6%, respectively, in 2013. Platelet transfusion justifications and determinants remained similar, except for severe intraventricular hemorrhage being an additional determinant in 2021.
Discussion
Restrictive local transfusion thresholds in a NICU decreased the proportion of platelet‐transfused neonates by 46% and reduced donor exposure in transfused patients.